These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1944727)

  • 1. Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model.
    Luke DR; Wasan KM; Verani RR; Brunner LJ; Berens KL; Vadiei K; Lopez-Berestein G
    Nephron; 1991; 59(1):139-44. PubMed ID: 1944727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the treatment of experimental candidiasis with vascular decongestants.
    Luke DR; Wasan KM; McQueen TJ; Lopez-Berestein G
    J Infect Dis; 1990 Jul; 162(1):211-4. PubMed ID: 2355196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis.
    Wasan KM; Vadiei K; Luke DR; Keyhani A; White RA; McQueen TJ; Mehta R; Lopez-Berestein G
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2046-8. PubMed ID: 1759826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of amphotericin B-cyclosporine interaction in the rat.
    Langston JD; Wasan KM; Lopez-Berestein G; Verani RR; Luke DR
    Transplantation; 1990 Sep; 50(3):506-10. PubMed ID: 2205957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline in amphotericin B toxicity rat model.
    Wasan KM; Vadiei K; Lopez-Berestein G; Verani RR; Luke DR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):241-4. PubMed ID: 2327772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
    Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
    Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of vascular decongestion in glycerol-induced acute renal failure.
    Luke DR; Berens KL; Verani RR
    Ren Fail; 1991; 13(2-3):61-9. PubMed ID: 1957044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines.
    Leon CG; Lee J; Bartlett K; Gershkovich P; Wasan EK; Zhao J; Clement JG; Wasan KM
    Lipids Health Dis; 2011 Aug; 10():144. PubMed ID: 21854638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.
    Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
    J Infect Dis; 1984 Aug; 150(2):278-83. PubMed ID: 6470530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of liposomal-amphotericin B against C. albicans infection in mice.
    Lopez-Berestein G; McQueen T; Mehta K
    Cancer Drug Deliv; 1985; 2(3):183-9. PubMed ID: 4052931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.
    Wasan KM; Rosenblum MG; Cheung L; Lopez-Berestein G
    Antimicrob Agents Chemother; 1994 Feb; 38(2):223-7. PubMed ID: 8192447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination.
    Mehta RT; Lopez-Berestein G; Hopfer RL; Mehta K; White RA; Juliano RL
    Antimicrob Agents Chemother; 1985 Oct; 28(4):511-3. PubMed ID: 4073873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
    Ribeiro TG; Franca JR; Fuscaldi LL; Santos ML; Duarte MC; Lage PS; Martins VT; Costa LE; Fernandes SO; Cardoso VN; Castilho RO; Soto M; Tavares CA; Faraco AA; Coelho EA; Chávez-Fumagalli MA
    Int J Nanomedicine; 2014; 9():5341-53. PubMed ID: 25429219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pentoxifylline and related analogues in endotoxemic renal failure.
    Berens KL; Langston JD; Wasan KM; Luke DR
    Circ Shock; 1991 Jul; 34(3):344-8. PubMed ID: 1884436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat treatment of amphotericin b modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits.
    Kwong EH; Ramaswamy M; Bauer EA; Hartsel SC; Wasan KM
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2060-3. PubMed ID: 11408223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.
    Vadiei K; Lopez-Berestein G; Luke DR
    Int J Obes; 1990 Jun; 14(6):465-72. PubMed ID: 2401582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.
    Kirsh R; Goldstein R; Tarloff J; Parris D; Hook J; Hanna N; Bugelski P; Poste G
    J Infect Dis; 1988 Nov; 158(5):1065-70. PubMed ID: 3183418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of nephrotoxicity of amphotericin B during the treatment of deep candidiasis].
    Jacqz E; Branch RA; Heidemann H; Aujard Y
    Ann Biol Clin (Paris); 1987; 45(6):689-93. PubMed ID: 3326441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.